Posted on August 11th, 2010 by Health News
(MedPage Today) –
No Comments »
Filed under: General Health News
Health News
News about health, pharmacy and medical care
Medical Tourists at Risk for New ‘Superbug’ (CME/CE)
Posted on August 11th, 2010 by Health News
(MedPage Today) — Some British residents who traveled to India or Pakistan for medical procedures appear to have picked up multidrug-resistant enterobacteria and carried the dangerous pathogens back home, researchers said.
No Comments »
Filed under: General Health News
Antibiotic Use Up After Part D (CME/CE)
Posted on August 11th, 2010 by Health News
(MedPage Today) — Implementation of Medicare Part D prescription drug coverage was followed by an increase in the use of antibiotics by older adults, researchers found.
No Comments »
Filed under: General Health News
WHO Unveils H1N1 Committee
Posted on August 11th, 2010 by Health News
(MedPage Today) — The World Health Organization has released the names and affiliations of the previously anonymous members of the emergency committee that has been advising the agency on pandemic H1N1 influenza.
No Comments »
Filed under: General Health News
FDA Extends Use of CMV Drug After Transplant
Posted on August 11th, 2010 by Health News
WASHINGTON (MedPage Today) — To protect against cytomegalovirus infections in kidney transplant patients, the FDA has okayed use of valganciclovir hydrochloride (Valcyte) for 200 days, doubling its original approved length of therapy.
No Comments »
Filed under: General Health News
Cooler Temps May Increase MI Risk (CME/CE)
Posted on August 11th, 2010 by Health News
(MedPage Today) — Colder weather may add up to more myocardial infarctions, researchers have found.
No Comments »
Filed under: General Health News
FDA Extends Use of CMV Drug After Transplant
Posted on August 11th, 2010 by Health News
WASHINGTON (MedPage Today) — To protect against cytomegalovirus infections in kidney transplant patients, the FDA has okayed use of valganciclovir hydrochloride (Valcyte) for 200 days, doubling its original approved length of therapy.
No Comments »
Filed under: Pharmacy News
HemaQuest commences HQK-1004 global Phase 2 clinical trial in EBV-related malignancies
Posted on August 11th, 2010 by Health News
HemaQuest Pharmaceuticals announced today that it has initiated the Company’s Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with [...]
No Comments »
Filed under: Pharmacy News
PolyMedix’s PMX-60056 Phase 1B/2 dose-ranging clinical study for heparin reversal meets study endpoints
Posted on August 11th, 2010 by Health News
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a Phase 1B/2 dose-ranging clinical study with PMX-60056, a synthetic small-molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
No Comments »
Filed under: Pharmacy News
Agile initiates Phase 3 NEW CHOICE Study of AG200-15 contraceptive patch
Posted on August 11th, 2010 by Health News
Agile Therapeutics, Inc., a pharmaceutical development company specializing in women’s healthcare products, today announced study initiation and dosing of the first patient in the Company’s pivotal, Phase 3 NEW CHOICE Study of AG200-15, Agile’s lead contraceptive patch. AG200-15 is designed to effectively deliver a low dose of estrogen in combination with levonorgestrel. The patch is [...]
No Comments »
Filed under: Pharmacy News
